The Many Faces of JAKs and STATs Within the COVID-19 Storm
The positive-sense single stranded RNA virus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), resulted in a global pandemic with horrendous health and economic consequences not seen in a century. At a finer scale, immunologically, many of these devastating effects by SARS-CoV-2 can be...
Main Authors: | Alice H. Grant, Armando Estrada, Yoshira M. Ayala-Marin, America Y. Alvidrez-Camacho, Georgialina Rodriguez, Elisa Robles-Escajeda, Denisse A. Cadena-Medina, Alejandro C. Rodriguez, Robert A. Kirken |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.690477/full |
Similar Items
-
Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis
by: Camille Keenan, et al.
Published: (2021-02-01) -
Characterization of JAK1 Pseudokinase Domain in Cytokine Signaling
by: Juuli Raivola, et al.
Published: (2019-12-01) -
Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients
by: Joaquim Bosch-Barrera, et al.
Published: (2020-06-01) -
Interleukin-6 Blocking vs. JAK-STAT Inhibition for Prevention of Lung Injury in Patients with COVID-19
by: Joseph Meletiadis, et al.
Published: (2020-08-01) -
Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies
by: Ethan L. Morgan, et al.
Published: (2020-09-01)